About the position
The Director of Pricing and Market Access Strategy Oncology will be responsible for the overall Global Market Access (GMAx) Strategy for one or more of BMS's portfolio assets or combination of assets in the targeted therapy oncology space. They will provide input to the Development and Commercial Strategy organization on access approaches globally (US and ex-US). Additionally, they will be responsible for representing integrated MAx input on above-brand portfolio strategy and portfolio prioritization decisions. The Director Pricing and Market Access Strategy Lead (PASL) Oncology will report to the Executive Director Pricing and Market Access Strategy Oncology. The position is highly strategic and cross-functional in nature, and is part of a highly-matrixed organization. The PASL will partner with the cross-functional GMAx Team as well as with the extended team (commercial, medical, regulatory, clinical, advocacy, policy, business Insights & analytics global leads), and with the relevant individual market stakeholders across the world to optimally position BMS products for success in an increasingly challenging and evolving WW access landscape. A motivated, inclusive, and decisive disposition is essential for success. It is critical that the successful candidate be highly informed on Global Pricing and Access strategy, have a track record of making complex strategic decisions, and can communicate strategy effectively to senior leaders across functions.
Responsibilities
- Lead development of an integrated Global Market Access strategy for BMS' in-line and pipeline Oncology Medicines/assets for relevant assets/indications.
- Ensure that the Pricing and Market Access Strategy is supported by strong Payer Value Propositions articulating bold and differentiated messages on clinical, humanistic, and economic benefits.
- Lead GMAx input to the Global Product Team to ensure Pricing and Market Access perspective is incorporated into development plans.
- Collaborate with the full GMAx organization to holistically assess BMS' Oncology assets, maximizing both speed of access and long-term franchise value.
- Lead the Global MAx Core Value Team and Value Strategy Team for relevant assets/indications.
- Work with Commercial, Medical, Business Insights and Analytics teams and local markets to monitor external environment and synthesize input to inform Market Access strategy throughout the drug's life cycle.
- Effectively navigate matrix to develop and maintain positive relationships with other functional areas and Market Access colleagues.
Requirements
- Undergraduate degree required, MBA and/or post graduate degree (PHD, MPH, MSc) in relevant field strongly desired.
- Understanding of the current and evolving global pricing and market access environment for Oncology products.
- At least 8 years' experience in the health care field.
- Knowledge of the product development and commercialization process.
- Proven ability to interpret and critique clinical study protocols.
- Launch / commercialization experience desired.
- Displays excellent business & financial acumen.
- Demonstrated ability to distill multiple perspectives and positions into a single set of recommendations.
- Proven ability to efficiently craft and accurately articulate pricing and access strategy to senior stakeholders.
- Demonstrated ability to lead cross-functional teams.
- Adept at navigating international, multi-lingual, and cross-functional organizational matrices.
- Experienced in prioritizing and managing multiple projects simultaneously.
Nice-to-haves
- Comfortable working in a rapidly evolving scientific and competitive landscape with a high degree of ambiguity.
- Ability to travel to international congresses and BMS internal meetings.
Benefits
- Competitive benefits, services and programs that provide resources to pursue goals at work and in personal lives.
